New Vaccine May Lead to Ground-breaking HIV Treatment

Armen Hareyan's picture

KANSAS CITY, Kan.- A University of Kansas School of Medicine researcher recently developed a DNA vaccine that is intended to take the place of expensive antiretroviral therapy for HIV patients. Bill Narayan, DVM, PhD, the principal investigator of a decades-long research project on studying HIV-like viruses, was awarded a $3 million grant from the National Institutes of Health to test the HIV vaccine on monkeys.

If these trials go well, he could receive more money to start clinical trials.

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.